Cornering metastases: Therapeutic targeting of circulating tumor cells and stem cells

Frontiers in Oncology

Volumn 2 JUL, Issue , 2012, Pages

  Faltas, Bishoy ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer stem cell; Circulating tumor cells; Epithelial mesenchymal transition; Immuno magnetic separation; Metastasis; Selectin ligands; Targeted therapy

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; SELECTIN; SMALL INTERFERING RNA;

CANCER SURVIVAL; CELL ADHESION; CIRCULATING TUMOR CELL; HUMAN; IMMUNOLOGY; METASTASIS; MORBIDITY; MORTALITY; NANOTECHNOLOGY; NONHUMAN; REVIEW; SOLID TUMOR; STEM CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84872652204     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00068     Document Type: Review

References (49)

1. Aalaoui-Jamali, M., Bijian, K., and Batist, G. (2011). Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives. Am. J. Transl. Res. 3, 434-444.
2. Armstrong, A., and Eck, S. L. (2003). EpCAM: a new therapeutic target for an old cancer antigen. Cancer Biol. Ther. 2, 320-326.
3. Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., and Gilles, C. (2010). Epithelial-to-mesenchymal transitions and circulating tumor cells. J. Mammary Gland Biol. Neoplasia 15, 261-273.
4. Chaffer, C. L., and Weinberg, R. A. (2011). A perspective on cancer cell metastasis. Science 331, 1559-1564.
5. Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Koop, S., Morris, V. L., Khokha, R., and Groom, A. C. (1995). Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev. 14, 279-301.
6. Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Morris, V. L., and Groom, A. C. (2000). Clinical targets for anti-metastasis therapy. Adv. Cancer Res. 79, 91-121.
7. Comen, E., Norton, L., and Massague, J. (2011). Clinical implications of cancer self-seeding. Nat. Rev. Clin. Oncol. 8, 369-377.
8. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W., and Hayes, D. F. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781-791.
9. Duffy, M. J., McGowan, P. M., and Gallagher, W. M. (2008). Cancer invasion and metastasis: changing views. J. Pathol. 214, 283-293.
10. Faltas, B. (2010). Targeting hematogenous spread of circulating tumor cells by a chemotactic drug-eluting IVC filter to prevent pulmonary and systemic metastasis. Med. Hypotheses 74, 668-669.
11. Faltas, B., Zeidan, A., Peters, K., Das, A., Joudeh, J., Navaraj, A., Dolloff, N. G., Harvey, H. A., Jiang, Y., Allen, J. E., Dicker, D. T., and El Deiry, W. S. (2011). Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting. J. Clin. Oncol. 29, 2946-2947; author reply 2947-2948.
12. Galanzha, E. I., Kim, J. W., and Zharov, V. P. (2009b). Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells. J. Biophotonics 2, 725-735.
13. Galanzha, E. I., Shashkov, E. V., Kelly, T., Kim, J. W., Yang, L., and Zharov, V. P. (2009a). In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat. Nanotechnol. 4, 855-860.
14. Gires, O., Klein, C. A., and Baeuerle, P. A. (2009). On the abundance of EpCAM on cancer stem cells. Nat. Rev. Cancer 9, 143; author reply 143.
15. Huang, Z., and King, M. R. (2009). An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation. Gene Ther. 16, 1271-1282.
16. Hughes, A. D., and King, M. R. (2012). Nanobiotechnology for the capture and manipulation of circulating tumor cells. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4, 291-309.
17. Iinuma, H., Watanabe, T., Mimori, K., Adachi, M., Hayashi, N., Tamura, J., Matsuda, K., Fukushima, R., Okinaga, K., Sasako, M., and Mori, M. (2011). Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with dukes' stage B and C colorectal cancer. J. Clin. Oncol. 29, 1547-1555.
18. Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L., and Massague, J. (2009). Tumor self-seeding by circulating cancer cells. Cell 139, 1315-1326.
19. Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312.
20. Kruck, S., Gakis, G., and Stenzl, A. (2011). Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors. Anticancer Res. 31, 2053-2057.
21. LaBarge, M. A., and Bissell, M. J. (2008). Is CD133 a marker of metastatic colon cancer stem cells? J. Clin. Invest. 118, 2021-2024.
22. Lee, A. A. (2009). Cutting edge: microfluidic-micromagnetic blood cleansing device. Lab Chip 9, 1167.
23. Liljefors, M., Nilsson, B., Fagerberg, J., Ragnhammar, P., Mellstedt, H., and Frodin, J. E. (2005). Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma. Int. J. Oncol. 26, 1581-1589.
24. MacDonald, I. C., Groom, A. C., and Chambers, A. F. (2002). Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays 24, 885-893.
25. Marangoni, E., Lecomte, N., Durand, L., de Pinieux, G., Decaudin, D., Chomienne, C., Smadja-Joffe, F., and Poupon, M. F. (2009). CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts. Br. J. Cancer 100, 918-922.
26. Miller, M. C., Doyle, G. V., and Terstappen, L. W. (2010). Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2010, 617421.
27. Mina, L. A., and Sledge, G. W. Jr. (2011). Rethinking the metastatic cascade as a therapeutic target. Nat. Rev. Clin. Oncol. 8, 325-332.
28. Monteiro, J., and Fodde, R. (2010). Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur. J. Cancer 46, 1198-1203.
29. Morris, V. L., Schmidt, E. E., MacDonald, I. C., Groom, A. C., and Chambers, A. F. (1997). Sequential steps in hematogenous metastasis of cancer cells studied by in vivo videomicroscopy. Invasion Metastasis 17, 281-296.
30. Nichols, A. C., Lowes, L. E., Szeto, C. C., Basmaji, J., Dhaliwal, S., Chapeskie, C., Todorovic, B., Read, N., Venkatesan, V., Hammond, A., Palma, D. A., Winquist, E., Ernst, S., Fung, K., Franklin, J. H., Yoo, J., Koropatnick, J., Mymryk, J. S., Barrett, J. W., and Allan, A. L. (2011). Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system. Head Neck. doi: 10.1002/hed.21941 [Epub ahead of print].
31. O'Flaherty, J. D., Gray, S., O'Leary, J. J., Blackhall, F. H., and O'Byrne, K. J. (2011). Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 76, 19-25.
32. Rana, K., Liesveld, J. L., and King, M. R. (2009). Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol. Bioeng. 102, 1692-1702.
33. Scarberry, K. E., Dickerson, E. B., McDonald, J. F., and Zhang, Z. J. (2008). Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. J. Am. Chem. Soc. 130, 10258-10262.
34. Scarberry, K. E., Dickerson, E. B., Zhang, Z. J., Benigno, B. B., and McDonald, J. F. (2010). Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles. Nanomed. Nanotechnol. Biol. Med. 6, 399-408.
35. Scarberry, K. E., Mezencev, R., and McDonald, J. F. (2011). Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression. Nanomedicine (Lond.) 6, 69-78.
36. Scheinberg, D. A., Villa, C. H., Escorcia, F. E., and McDevitt, M. R. (2010). Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nat. Rev. Clin. Oncol. 7, 266-276.
37. Sleeman, J. P., Nazarenko, I., and Thiele, W. (2011). Do all roads lead to Rome? routes to metastasis development. Int. J. Cancer 128, 2511-2526.
38. Subramaniam, V., Vincent, I. R., Gilakjan, M., and Jothy, S. (2007). Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy. Exp. Mol. Pathol. 83, 332-340.
39. Swaby, R. F., and Cristofanilli, M. (2011). Circulating tumor cells in breast cancer: a tool whose time has come of age. BMC Med. 9, 43. doi: 10.1186/1741-7015-9-43
40. Takeuchi, H., and Kitagawa, Y. (2010). Circulating tumor cells in gastrointestinal cancer. J. Hepatobiliary Pancreat. Sci. 17, 577-582.
41. Valastyan, S., and Weinberg, R. A. (2011). Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292.
42. Waldron, N. N., Kaufman, D. S., Oh, S., Inde, Z., Hexum, M. K., Ohlfest, J. R., and Vallera, D. A. (2011). Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Mol. Cancer Ther. 10, 1829-1838.
43. Wang, J., Sakariassen, P. O., Tsinkalovsky, O., Immervoll, H., Boe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., Molven, A., Bjerkvig, R., and Enger, P. ø. (2008). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122, 761-768.
44. Weight, R. M., Viator, J. A., Dale, P. S., Caldwell, C. W., and Lisle, A. E. (2006). Photoacoustic detection of metastatic melanoma cells in the human circulatory system. Opt. Lett. 31, 2998-3000.
45. Wittekind, C., and Neid, M. (2005). Cancer invasion and metastasis. Oncology 69(Suppl. 1), 14-16.
46. Wojciechowski, J. C., Narasipura, S. D., Charles, N., Mickelsen, D., Rana, K., Blair, M. L., and King, M. R. (2008). Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device. Br. J. Haematol. 140, 673-681.
47. Wong, C. W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., Al-Mehdi, A. B., Bernhard, E. J., and Muschel, R. J. (2001). Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333-338.
48. Yu, M., Stott, S., Toner, M., Maheswaran, S., and Haber, D. A. (2011). Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373-382.
49. Yung, C. W., Fiering, J., Mueller, A. J., and Ingber, D. E. (2009). Micromagnetic-microfluidic blood cleansing device. Lab Chip 9, 1171-1177.